These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22072157)

  • 21. Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials.
    Yin J; Deng H; Qin S; Tang W; Zeng L; Zhou B
    Diabetes Res Clin Pract; 2014 Sep; 105(3):e10-5. PubMed ID: 25005849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes: target HbA1c of about 7%.
    Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summaries for patients: Oral drug treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.
    Ann Intern Med; 2012 Feb; 156(3):I36. PubMed ID: 22312157
    [No Abstract]   [Full Text] [Related]  

  • 24. The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
    Morales J; Assumpcao-Morales M
    Diabetes Obes Metab; 2018 Aug; 20(8):1809-1811. PubMed ID: 29658190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saxagliptin is similar in glycaemic variability more effective in metabolic control than acarbose in aged type 2 diabetes inadequately controlled with metformin.
    Wang MM; Lin S; Chen YM; Shu J; Lu HY; Zhang YJ; Xie RY; Zeng LY; Mu PW
    Diabetes Res Clin Pract; 2015 Jun; 108(3):e67-70. PubMed ID: 25841300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glyburide/metformin HCl clinical overview.
    Seymour A
    Manag Care; 2001 Feb; 10(2 Suppl):11-6. PubMed ID: 11729403
    [No Abstract]   [Full Text] [Related]  

  • 27. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twice-daily dapagliflozin co-administered with metformin in type 2 diabetes: a 16-week randomized, placebo-controlled clinical trial.
    Schumm-Draeger PM; Burgess L; Korányi L; Hruba V; Hamer-Maansson JE; de Bruin TW
    Diabetes Obes Metab; 2015 Jan; 17(1):42-51. PubMed ID: 25200570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canagliflozin in Asian patients with type 2 diabetes on metformin alone or metformin in combination with sulphonylurea.
    Ji L; Han P; Liu Y; Yang G; Dieu Van NK; Vijapurkar U; Qiu R; Meininger G
    Diabetes Obes Metab; 2015 Jan; 17(1):23-31. PubMed ID: 25175734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When metformin fails in type 2 diabetes mellitus.
    Esposito K; Bellastella G; Giugliano D
    Arch Intern Med; 2011 Feb; 171(4):365-6. PubMed ID: 21357815
    [No Abstract]   [Full Text] [Related]  

  • 31. Gender-related different effects of a combined therapy of Exenatide and Metformin on overweight or obesity patients with type 2 diabetes mellitus.
    Quan H; Zhang H; Wei W; Fang T
    J Diabetes Complications; 2016; 30(4):686-92. PubMed ID: 26873871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled phase III trials.
    Del Prato S; Taskinen MR; Owens DR; von Eynatten M; Emser A; Gong Y; Chiavetta S; Patel S; Woerle HJ
    J Diabetes Complications; 2013; 27(3):274-9. PubMed ID: 23403068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin and lipoprotein(a) levels.
    Kiayias JA; Vlachou ED; Papadodima EL
    Diabetes Care; 1999 May; 22(5):859. PubMed ID: 10332699
    [No Abstract]   [Full Text] [Related]  

  • 34. Type 2 diabetes: which glucose-lowering drug, if any, after metformin?
    Prescrire Int; 2015 May; 24(160):135. PubMed ID: 26034807
    [No Abstract]   [Full Text] [Related]  

  • 35. Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes.
    Raccah D; Gourdy P; Sagnard L; Ceriello A
    Diabetes Metab Res Rev; 2014 Nov; 30(8):742-8. PubMed ID: 24687427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial.
    Pratley RE; Eldor R; Raji A; Golm G; Huyck SB; Qiu Y; Sunga S; Johnson J; Terra SG; Mancuso JP; Engel SS; Lauring B
    Diabetes Obes Metab; 2018 May; 20(5):1111-1120. PubMed ID: 29266675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
    Bays HE
    Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New therapeutic approaches in type 2 diabetes mellitus].
    Zafon C
    Med Clin (Barc); 2015 Dec; 145(11):485-7. PubMed ID: 26142571
    [No Abstract]   [Full Text] [Related]  

  • 39. The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data.
    Lin SD; Wang JS; Hsu SR; Sheu WH; Tu ST; Lee IT; Su SL; Lin SY; Wang SY; Hsieh MC
    J Diabetes Complications; 2011; 25(5):332-8. PubMed ID: 21813293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.